MITCHEL B. SAYARE, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Altimmune, Inc.

Filing Date Source Excerpt
2012-04-30 Dr. Sayare holds a Ph.D. in Biochemistry and has served as CEO and Chairman of biotechnology companies.
2013-04-30 Dr. Sayare was primarily chosen to serve as a director because of his substantial experience as a board member and executive officer of biotechnology companies.
2014-05-08 Dr. Sayare was chosen to serve as a Director because of his substantial experience as a Board member and executive officer of biotechnology companies.
2015-04-30 Dr. Sayare earned a Ph.D. in biochemistry from Temple University School of Medicine. Dr. Sayare was chosen to serve as a director because of his substantial experience as a Board member and executive officer of biotechnology companies.
2016-04-29 Dr. Sayare earned a Ph.D. in biochemistry from Temple University School of Medicine. Dr. Sayare was chosen to serve as a director because of his substantial experience as a Board member and executive officer of biotechnology companies.
2017-09-01 Dr. Sayare earned a Ph.D. in biochemistry from Temple University School of Medicine.

Data sourced from SEC filings. Last updated: 2026-03-05